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Article 6

Contraception and Abortion,
Foes or Friends?
by

The Rev. Mons. Jacques Suaudeau
The author, who is both a medical doctor and a priest, serves as an
official for the Pontifical Council jor the Family, in the Vatican.

Thirty-two years ago, July 26, 1968, in the midst of the "sexual liberation"
wave, Pope Paul VI gave his famous encyclical Humanae Vitae, in which
he condemned with clarity and firmness the use of any contraceptive
technique for "family planning" purposes.
All these years later, the time has come to make a judgment on the
insight of this encyclical , with a better knowledge of the physical and moral
consequences of the contraceptive pill.
The promoters of contraception opposed the moral judgment of Pope
Paul VI. They presented the so-called " pill" as an antiovulatory agent,
respectful of human life, with nothing intrinsically wrong attached to its
action. And they insisted on the fact that the pill was " the most effective
remedy against abortion" (Evangelium Vitae nO 13), and, as such, a true gift
to humanity.
In the following report we would like to answer these two questions,
in the light of present knowledge :
• Are oral contraceptives respectful of human life?
• Is contraception the true way of preventing abortion?
We will deal here only with oral contraception I , either as combined
estrogen-progestogen preparation - the so-called "contraceptive pill" - or
as low-dose, progestogen-only preparation, the so-called " mini-pill."
We will not consider in thi s study the other methods of modem
contraception - " postcoital contraception", long-lasting intramuscular
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injectable progestogen, implants, and intrauterine devices, because they are
clearly abortive in their action and outside of the eth ics ofcontraception .2

I. The Abortivity of Oral Contraceptives
Oral contraceptives have been presented as purely antiovulatory
agents, and all the discussion which preceded and immediately followed
the publication of the encyclical Humanae Vitae took this affirmation for
granted. However as early as the 1950s3 it was already clear that the
mechanism of the highly effective compound estrogen-progestogen could
not be limited to a pure prevention of ovulation . Today, for the combined
oral contraceptive and, even more, for the progestogen-only pill, an
abortifacient action has been demonstrated which does change the ethical
perspective about these contraceptives.

A. The Estrogen-Progestogen PiII 4
It is known today that the infertility which results from the action of
combined oral contraceptives is caused by the intervention of these
compounds on least at three levels :
• on the hypothalamic-pituitary-ovarian axis
• on the cervical mucus
• on the uterine endometrium

1) Ovarian function is generally suppressed, but some "escape ovulations"
do happen with combined oral contraceptives.
The inhibition of ovulation by estrogen-progestogen compounds is
5
strong. The first contraceptive pills which were delivered to the market in
the 60s contained high concentrations of estrogens and progestogens and
certainly acted by blocking ovulation . The initial formulation of the
combined oral contraceptives was of 0.150 mg. mestranol, 9.85 mg.
norethynodrel. Mestranol was then replaced by the more potent Ethinyl
Estradiol, which made it possible to reduce the dose of estrogen in the pill.
Because of the incidence of side effects and complications, especially
thromboembolism, associated with the use of these early contraceptive
pills, respective concentrations of estrogens and progestogens in the
contraceptive pill subsequently have been reduced. The first important
change occurred in the late 1960s when there was a massive shift from
higher dose pills to the "classic" pill, containing on ly 50flg. of estrogen (as
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ethinyl estradiol) and a lower dose of progestogen (1 mg. of a 19
nortestosterone derivative, as an example, norethisterone acetate).
These preparations were themselves superseded in the mid-1970s by
" low-dose pills", containing only 30-40 ).lg. estrogen and I mg. or less
progestogen . Finally, in the 1980s, phasic and 20 ).lg. ethinyl estradiol
preparations were introduced.
A more relative inhibition of the pituitary gonadotropic function 6 has
resulted from this lowering of the doses of active ingredients in the
contraceptive pill, allowing more elevated plasmatic concentrations of FSH
(Follicle Stimulating Hormone) and of LH (Luteinizing Hormone)7, and
therefore a less effective suppression of ovarian activity.8 Indeed,
plasmatic concentrations of estradiol and progesterone remain low when
oral contraception is sought after with these new low-dose compounds. 9
These formulations , which contain less of the steroids 10, as well as the
triphasic compositions, do inhibit effectively the pituitary-ovarian
function . I I However, the effectiveness of their antiovulatory action can be
incomplete in those persons who are more resistant to this inhibition. 12
Taking certain medications jointly with oral contraceptives (especially
psychotropic drugs and antibiotics), and the occurrence of gastrointestinal
disturbances (gastroenteritis, diarrhea), can also lessen the ovarian
suppression activity of the oral contracepti ves. 13
Even in these studies where relatively important doses of ethinyl
estradiol (50 ).lg.) are used , the LH urinary elimination remains within the
limits of normality, and in some women (in one cycle out of five), the study
of plasmatic estradiol concentrations shows that ovarian follicles do
develop despite the use of the contraceptive pill (Elstein et coil., 1974)14
Ultrasonographic scanning of the ovaries confirm that, in 30 to 50% of the
treatment cycles, ovarian follicle-like structures do develop to a diameter of
15
10 mm or greater, before gradually diminishing in size.
When women
were monitored by daily pel vic ultrasonography along the whole cycle, it
has been found that, in at least 5% of the cycles, a rupture of the follicle
16
wall occurred and ovulation was then detected.
Hormonal assessment in
blood confirmed the reality of these ovulations.
Thus, with the pills offered today on the market, ovulations are indeed
17
verified despite contraception, at the rate of one for ten or twelve cycles.
Such "escape ovulations" can be followed by fertilization , if there is sexual
intercourse within the five days following the ovulation .
2) Combined oral contraceptives thicken cervical mucus
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It is probable that part of the contraceptive effect of the estrogensprogestogens compounds is due to their action on the uterine cervix. They
transform cervical mucus into the progestogenic type, thick and scanty,
with impaired spin-barkeit and poor or no ferning pattern . IS This makes it
19
more difficult for the spermatoza to penetrate across the cervix.

3) Combined oral contraceptives impair endometrial receptivity
The third way in which combined oral contraceptives may achieve
female sterility is by maintaining the uterine endometrium in an atrophic
state, non-receptive to the implantation of a possible embryo. Here, it is the
gestogen part of the contraceptive which is responsible. It provokes a
morphological dystrophy of the uterine mucous membrane ?O
Histological stud/I of endometrial biopsies from women taking
combined oral contraceptives shows that from cycle day 5 through 24 the
proliferation of endometrial glands is suppressed. At first the stroma
appears dense and fibrous , then it becomes edematous, and eventually it
may undergo pseudodecidual changes. Arterioles are poorly developed or
absent from large areas of the endometrium ; venules, however, may
sometimes be dilated to large sinuses; in contrast to the suppression of
glandular proliferation, the secretory activity is accelerated at the
beginning. However, it decreases from mid-cycle on and the glands then
remain narrow and straight. The secretory activity of the endometrium
never develops to the extent characteristic of the late secretory phase of a
menstrual cycle.
Examined under scanning and transmission electron microscopy,
endometrial surface appears altered, with fewer ciliated cells and
incomplete secretory modifications. 22
Endosonographic assessment 23
shows that, in women taking low-dose combined oral contraceptives, the
endometrial thickness is lower than 8 mm for all cycles, showing a
pronounced effect of the oral contraceptives on the endometrium, which
impairs endometrial receptivity.
The study in endometrial tissue specimens of the expression of these
integrins which are closely associated with endometrial receptivity
4
(Somkuti et aI. , 1996l , shows that in the endometrium of combined oral
contraceptive users, there are significant alterations in cycle-dependent
integrin expression (a 1(31 , a4(31 and av(33) with a specifically increased
glandular a4(31 and decreased av(33 expression . This altered expression of
the integrins corresponds to an unreceptive endometrium and predisposes
to implantation failure or early pregnancy loss. These alterations thus
provide evidence that the morphological changes observed in the
endometrium of women taking combined oral contraceptives have
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functional significance and that reduced endometrial recepttvlty does
indeed contribute to the contraceptive effect of the oral contraceptives.
4) The abortive effect of combined oral contraceptives
From this study, we can conclude that the present combined oral
contraceptives do allow on one hand some development of ovarian follicles
with possible ovulation and subsequent fertilization , and, on the other hand,
makes impossible the nidation of the product of this fertilization.
Therefore, they do have an abortifacient effect.
We lack a reliable and easy to use method to detect a living embryo
before its implantation. Therefore, it is not possible to have a precise idea
of how many early abortions can be brought on by the use of combined oral
contraceptives. We can only make a guess from the difference calculated
between the total number of poss ible escape ovulations and the number of
actual pregnancies observed in women taking oral contraceptives.
If we assume that escape ovulations do happen in 5% of the cycles
while taking combined oral contraceptives, and if we estimate that
fertilization can follow in 25% of these cases we would have a possibility
of 1.25 fertilizations for 100 cycles. That is around ten fertilizations for
100 women per year. Taking into account the Pearl index for combined
5
oral contraceptives which is around 1/ we would have for each one
embryo able to implant and develop despite contraception, nine embryos
eliminated early due to reduced endometrial receptivity. This means that a
woman taking low-dose combined oral contraceptives for 15 years would
lose approximately 1.3 embryos in this way. 26

B. Progestogen-Only Pills (The Mini-Pill)
The situation is quite different with the low-dose progestogen-only
pills. These have been developed in recent years as an alternative to
combined oral contraceptives. Called ·'mini-pills,,27 because of their
reduced steroid content28 , these compounds are particularly well-suited to
women with contraindications to the estrogen in combined oral
contraceptives, for women who experience side effects with the combined
pill, for breastfeeding mothers, and for older women.
I) Progestogen-only pills do not suppress ovarian activity
Different from combined oral contraceptives, progestogen-only pills
do not have a significant action on the hypothalamic-pituitary-ovarian
axis. 29 They suppress ovulation in less than 50% of the contraceptive
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cycles. 30 Most of the cycles during low-dose pregestogen administration
are probably ovulatory, as suggested by endometrial morphology and
clinical determinations. 31 As a result, an important follicular activity32,
33
inversely proportional to the amount of administered progestogen , can be
evidenced in women taking this kind of oral contraceptives.

2) Progestogen-only pills thicken cervical mucus
Under the effect of progestogen-only oral contraceptives, cervical
34
mucus is highly viscous, scanty, opaque, and cellular , gestagenic-type. 35
The meshwork which constitutes the infrastructure of the cervical secretion
appears greatly tightened, giving the typical appearance of cervical mucus
in the late luteal phase. 36 On penetration tests, sperm cells remain on the
surface of the mucus or are trapped in the superficial layers of the woof.
Sperm penetration comes to a stop 3-4 cm from the sperm-mucus contact
point. 37 In vivo post-coital sperm penetration tests in women taking the
mini-pill show that, in 70-80 percent of the time, there is little or no
penetration . 38 A direct, sperm agglutinating effect of the progestogens in
vitro has also been reported . 39 However, some spermatozoa do pass
through the barrier of cervical mucus despite the tightening of its
40
meshwork.
Indeed, there is a relatively high incidence of ectopic
gestations in patients using progestogen-only oral contraception. 41 The
risk of ectopic pregnancy among women using this form of contraception
may be increased from two to five-fold when compared with women of
childbearing age. 42
3) Possible action on Fallopian tubes
A possible explanation of the high incidence of ectopic pregnancy in
mini-pill users is altered tubal motility. In vitro studies have shown that
19-norsteroids diminish the intensity and frequency of peristaltic tubal
43
movements.
On the other hand, a decrease of ciliation has also been
observed in the infundibular and ampullar regions of the oviduct, with
microvilli scarce and of irregular height in women given steroidal
contraceptive treatment.4~
But other investigators did not find any
abnormality upon histological examination of tubal epithelium in mini-pill
users.45 Progestins could also reduce the intensity and frequency of cilia
action, thus slowing the rate of ovum tran sport (McCann, 1994).46 On the
whole, there is no clear-cut evidence concerning these supposed effects.
4) Progestogen-only pills oppose the implantation of early embryos in the
endometrium
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It is the endometrium which is the main site of action of low-dose oral
progestagens. Progestagens interfere with the normal , cyclic development
47
of the endometrium , and in that way prevent the implantation of early
embryos. Animal studies have shown that progestogen makes implantation
impossible in 84% of all cases, which prevents pregnancies at a 100%
48
rate .
The endometrium of women taking low-dose, progestogen-only oral
contraceptives presents, during the first part of the contraceptive cycle, a
proliferative aspect, with varying degrees of mitotic activity.49 Early
secretory activity reaches a maximum on days 13 to 15, but never
progresses to a full development.
This abortive, secretory phase is
followed by a regression of the glands. 5o Suppression is total, during the
whole cycle, with glandular atrophy, compact stroma, fibrosis , moderate
decidual reaction, for women taking 300 J.lg norethindrone or 30 J.lg
norgestrel per day. 51 Electron microscopy shows that the endometrium in
development during the first part of the cycle presents an irregular
secretory pattern, with presecretory changes observed in some cells in each
gland while the remainder of the cell components retains proliferative
features. Such an irregular cell maturation is not compatible with a normal
52
implantation.
In agreement with this morphologic " suppression" of the
endometrium, studies of the action of oral progestogen-only contraceptives
53
on the uterine biochemistry of rats have shown have shown a general
depression of the metabolic status of the uterus . There is a diminution in
energy production in the uterus under the influence of the progestogen.
Therefore, low dose oral progestogens interfere with the cyclic
development of the endometrium, allowing either an irregular cellular
maturation, or suppressing it.
Under the mini-pill , the energetically
deprived uterus during conception would be in a " sleepy state" , unprepared
for the implantation of an embryo.

5) The abortive action of the " mini-pill."
Oral progestogen-only contraceptives neither suppress ovulation
consistently nor prevent totally the passage of spermatozoa through the
uterine cervix. So, it must be their suppressive action on the endometrium
which prevents development of a pregnancy. The mini-pill allows probable
fertilization in a large number of cases, but does not permit development of
an embryo - at least in the uterus - because it hinders its implantation.
Therefore this is not a contraceptive action but an abortifacient one.
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If we assume that ovulation can occur in 37% of the contraceptive
cycles of women taking the mini-pill, with fertilization following in 25% of
these cases, then nine fertilization s could occur per 100 cycles. That is to
say, 75 fertilizations occur per 100 women per year, in women taking the
mini-pill. Given that the Pearl index for the mini-pill varies between 1.5
and 6, with a mean value 54 of 3.75 (3 .1 for the 25-29 age group), 55 there
could be, for each 3.75 embryos able to implant and develop, 71 embryos
eliminated early per 100 women per year. Thus, a woman taking the minipill continuously would have about 10 early abortions during 15 years of
sexually active life. 56 However, given that the mini-pill is taken by less
than 10% of contraceptive users, the total amount of these abortions is
much smaller than the number of abortions caused by combined oral
contraceptives.
C. Discussion

Oral contraceptives, therefore, provoke early abortions, more than one
in her active sexual life for the woman taking the combined pill , and up to
ten abortions for the woman taking the mini-pill.
This cannot be
overlooked.
I) Is the number of abortions caused by oral contraceptives too small to be
considered a problem?
One could answer that the number of abortions related to the use of
oral contraceptives is relatively small when compared to the number of
spontaneous abortions which occur after fertilization and before
implantation, because of genetic defects, immunological incompatibilities,
57
But the fact that there may be spontaneous
or grave malformation.
abortions does not justify abortions caused by contraceptives, any more
than the daily occurrence of human death by car accidents could justify
homicide through planned auto collisions.
On the other · hand, if we relate the abortions induced by oral
contraceptives to the total number of women using such medications, we
arrive at some impressive figures . B. Bayle estimates, for example, that
between 120,000 to 400,000 embryos a year are aborted this way in France.
This is almost as many as there are induced abortions in that country.56
2) Are these abortions not to be considered as such because they concern
only pro-embryos?
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A second argument for not considering problematic those abortions
induced by oral contraceptives is to declare that they are not true embryos.
Different investigators, such as A. McLaren 59 and also theologians, such as
Rev. Norman Ford of Melburne, Australia 60 maintain indeed that, before
the 15th day following fertilization, or at least before its implantation in the
uterus (which starts approximately on day 5 after fertilization , the early
embryo cannot be considered as a true individual because its blastomeres
are totipotent and can multiply to form other embryos once detached, as
occurs naturally with monozygotic twins. 61
But the fact that a totipotent cell can divide into two individual beings
does not contradict the continuity in the development of the embryo.61 We
do not have in the early embryo an indeterminate system which could
originate, by division, two determinate systems. There is, instead, a first
being from which can arise, through accidental detachment of one cell,
another being with its own genetic program .
Some may also say, on theological grounds, that the embryos
eliminated by oral contraceptives do not have the same value as true human
beings because they have not yet been informed by a rational , human
64
soul. 63 Not only is this thesis philosophically incorrect , but it also lacks
any biological grounding. It has been indirectly disapproved by the Church
in repeated condemnations of induced abortions (Declaration on Procured
Abortion, Congregation for the Doctrine of the Faith, November 25 , 1974;
"extending from conception to birth," Evangelium Vitae 58).

II. Oral Contraception and the Practice of Abortion
After recognizing the abortive effect of oral contraceptives, one can
ask if the connection is limited to pharmacology and early embryology, or
if it goes further.
Rich from many points of view, the recent encyclical of Pope John
Paul II, Evangelium Vitae , has brought a new dimension to the discussion
of contraception started by Humanae Vitae . In commenting on the "antilife" aspects of contraception, the Pope declares:
Certainly, from the moral point of view, contraception and abortion
are specifically different evils: the former contradicts the full truth of
the sexual acts as the proper expression of conjugal love, while the
latter destroys the life of a human being; the former is opposed to the
virtue of chastity in marriage, the latter is opposed to the virtue of
justice and directly violates the divine commandment "You shall not
kill." But despite their differences of nature and moral gravity,
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contraception and abortion are often closely connected, as fruits of the
same tree ... (E .V. 13)

Thus, in this very important passage, John Paul" denounces not simply the
abortivity of the contraceptive pill, but the mere existence of a connection
which would exist between contraception and abortion.
A. The Assertion: "Contraception is the most effective remedy against
abortion. "
1) The position of the promoters of contraception.
This statement of John Paul " is all the more surprising because,
although it is the first time that such an accusation appears in an official
Church document, it directly opposes the basic argument of all the
promoters of " Family Planning", from the earliest days of the I.P.P.F. to the
more recent publications of the FNUAP or of the WHO on this question.
This argument lies in the quasi axiomatic affirmation that "contraception, if
made safe and available to all, is the most effective remedy against
abortion ."(E.V.13).
Following this argument, oral contraceptives would represent indeed a
"lesser evil" compared to the greater evil of voluntary abortion. The
promotion of oral contraception, because it would lead to a decrease in the
number of voluntary abortions, and particularly the unsafe ones, would be
therefore more than justified. On the contrary, opposition to contraception,
for religious or cultural reasons, would not do any good, because it would
increase recourse to abortion .65 The Catholic Church has actually been
accused of indirectly promoting abortion because of its intransigent stand
against hormonal contraception . John Paul" writes:
The Catholic Church is .. . accused of actually promoting abortion,
because she obstinately continues to teach the moral unlawfulness of
contraception (Evangelium Vitae 13).

Given this, one wonders why the Pope has judged it necessary to
disagree publicly with this opinion in the most official document of the
Church.
Neither Humanae Vitae nor any later document of the
Magisterium has dared to express such disagreement.
2) The position of Evangelium Vitae 13.
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If we now analyze this thesis in favor of promotion of contraception,
we find that in the assertion " Prevention is better than abortion", there is an
obvious weakness. The opposition between contraception and abortion is
taken for granted, and no effort is ever made to prove it. But does
increased contraception really mean decreased induced abortions? The
Holy Father expresses clear doubts about it, again in the same paragraph of
Evangelium Vitae:
When looked at carefully, this objection is clearly unfounded. It may
be that many people use contraception with a view to excluding the
subsequent temptation of abortion, but the negative values inherent in
the "contraceptive mentality" ... are such that they in fact strengthen this
temptation when an unwanted life is conceived. (£. V. 13)

John Paul II supports these doubts by the statement that it is precisely in the
places where the teaching of the Church on contraception is not welcomed
that abortion is strong:
Indeed, the pro-abortion culture is especially strong precisely where the
Church ' s teaching on contraception is rejected. (£. V. 13)

Thus, if we follow John Paul II, the practice of contraception, far from
bringing down the recourse to abortion, could in fact favor it.
This affirmation of John Paull II is not, in fact, based on mere
opinion. If in 1968, Pope Paul VI did not have the necessary data to bring
forth such an argument in Humanae Vitae due to the relative newness of
contraception then, statistics are now available which deomnstrate the
accuracy of the Pope's judgement. These statistics, which will only be
sampled in the present study, show that one passes easily from
contraception to abortion, that contraceptive users are the main applicants
for legal abortion.
Also, these statistics show that the spread of
contraception in different countries has not brought about the decrease in
voluntary abortions which had been expected.
B. The Practice of Contraception May Lead to Abortion .
I) Contraceptive users are the main applicants for abortion.
In a study carried out in Sweden 66 , on a sample of 2,621 women of
Gotebord, aged 19 to 24 years, followed from 1981 to 1986, and of whom
89% were using oral contraception, it was found that 43% of these became
pregnant during that period, and that 44% of these pregnancies were
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terminated by a legal abortion.
Thus, despite an easy access to
contraception and its general use, the abortion rate in that group remained
high.
In a study done in Finland from 1976 to 1993 ,67 to check the efficacy
of a promotion campaign for contraceptives among adolescents, the
investigators did find a decrease in the number of abortions, from 4,143 to
1,513 . However, the reduction observed in childbirth, from 5,376 to 1,655 ,
was even more important. These adolescents, while using contraception,
did in fact continue to have recourse to abortion. In all the provinces where
contraceptives were promoted, at the end of the 1990s, the number of
abortions did not drop but rose instead, and did not start to diminish before
the 1990s, in parallel with the drop in the birth rate. Thus, the first effect
of this promotion of contraceptives was to lead users to adopt a more
negative attitude toward respect for life of the unwanted child. 68
K. Sidenius and N.K. Rasmussen69 observe that 90% of the 110
teenagers admitted for an abortion in Herlev Hospital , Copenhagen,
Denmark, from 1977 to 1978, had previously received information on
contraception and that 60% of them did use some form of contraception.
Most of these adolescents had started to have sexual relationships before
age 15 . All of these abortions were therefore the result of contraception
failures.
The Allan Guttmacher Institute (affiliated with the American
Federation for Family Planning) published a study in 1996, carried out in
1994-1995 on 10,000 women who requested an abortion. This study shows
that 57 .5% of these women did use a contraceptive method, at least during
the month before contraception. 70
71
V.A .H. Pearson et al. , in a study publi shed in 1995 about undesired
pregnancies among adolescents, reported that 80% of these adolescents
declared that they were using a contraceptive during the period in which
they had conceived. These rather surprising results are corroborated by
72
E.S. Williams
who observed a proportion between the use of a
contraceptive at the time of the first sexual relations and the subsequent
occurrence of a pregnancy. As this proportion cannot be explained only by
contraceptive failures , this investigator suggests that the practice of
contraception may lead, among unmarried young persons, to an increase in
sexual promiscuity with a multiplication of the number of sexual relations.
This, in turn , would be responsible for the epidemic of unwanted
pregnancies.
2) Spread of modern methods of contraception has not brought the
expected drop in voluntary abortions.
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If we look now at the general statistics on abortion throughout the
different countries, we do not find a decrease in induced abortions since the
beginning of widespread contraception. More often, we find a plateau or
even a relative increase in abortions.
In the United States, for instance,73 the reported number of abortions
rose continuously, parallel to the spread of contraception, from 988,267 in
1972 to 1,429,577 in 1980, leveling off between 1980 and 1984. Between
1993 and 1994, the annual number declined from 22 to 21 per 1,000
women aged 14-44 years. This small decline is related to the parallel
decline in child birth.
In Great Britain74, in 1971 , 95 ,000 legal abortions were recorded per
783 ,000 births. That is one abortion for every eight births. In 1986, the
number of legal abortions grew to 148,000, while there were only 661 ,000
births. That is one abortion for every four births. Thus, the number of
voluntary abortions in this country did increase in a noticeable way,
precisely during the period when oral contraceptives were the most widely
promoted and used.
In France, the total number of registered abortions has only slightly
diminished in the last twenty years, from 250,00 per year in 1976,
immediately after the legalization of abortion , to 220,000 per year in
1994. 75 Meanwhile, contraception has become part of the life of French
women , with 70% of them between the age of I 8-49 using a contraceptive
method. 76
Mrs. Blayo, from the " lnstitut national d ' Etudes
Demographiques", has declared : " This slowness (in the diminution of
abortion) alarms those who thought that the spread of medica Ii zed and very
efficient contraceptive methods could rapidly resolve the problem ... To
encourage couples to an ever greater mastery of their reproduction
evidently brings them determination not to accept failures. "n In other
words, promotion of contraception leads people to more adamantly reject
the child who dares to present itself despite contraception.

C. Contraception ~nd abortion are " fruits of the same tree."
Faced with these results, one has to admit that contraception has
obviously not helped to d~crease abortion in the way expe~t~d. - This is
because one passes easily from contraception to abortion. Therefore, there
must be something in common between them, despite their obvious
differences. Pope John Paul II puts it this way in Evangelium Vitae:
The close connection which exists, in mentality, between the practice of
contraception and that of abortion is becoming increasingly obvious.
(£VI3) .
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M. Rhoneimer78 rightly observes that John Paul II does not say that
abortion is the consequence of an anti-life mentality which would be
already present in the contraceptive mentality. John Paul II writes instead:
... the negative values inherent in the "contraceptive mentality" - which
is very different from responsible parenthood ... are such that they in fact
strengthen this temptation (of abortion) when an unwanted life is
conceived.(EVI3)

Thus, for the Pope, contraception comes first , not as a mere by-product of
an anti-life mentality, but with its own negative specificity of contradicting
the truth of the sexual act. In the contraceptive mentality, it is not hate for
the life of a possible child which comes first. In fact, the possible child is
not even thought about. What comes first is the intention to have sexual
intercourse with someone of the other sex, with the associated intention to
prevent this freely decided sexual intercourse from giving origin to a new
life. Thus, as M. Rhonheimer puts it,79 the contraceptive mentality plunges
its roots into a sexual behavior in which one exonerates oneself from one' s
procreative responsibility. As a consequence, the parents who find
themselves with the " misfortune" of a conception, fruit of the failure of
contraception, do not feel truly responsible for this new life. They have
indeed chosen to not be the cause of a new life by excluding the procreative
dimension of their sexual acts. In this case, the baby is "truly unwanted."
Pope John Paul II puts it in Evangelium Vitae:
.. . abortion becomes the only possible decisive response to failed
contraception (E VI3).

In that perspective, it is understandable that a woman could enter into
the abortion mentality the same way she entered into the contraception
mentality. She does not, really, want to suppress a human life as such; she
does not even consider that life to be a real one. What she does want is not
to assume the responsibility of her sexual behavior. In both the acts of
contraception and abortion, there is a kind of self-inflicted blindness. The
woman considers only her own situation the conflict in which she feels
entangled and the way to protect herself from the unwanted consequences
of her sexual life. She will simply deny any value to the life which has
started in her body, against her lifestyle choice, or she will despise it.
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Conclusion
This study of the connections between oral contraception and
voluntary abortion suggests the following remarks:
1) In the quest for an " ideal contraceptive", more effective but with fewer
side effects and less risk of complication, pharmacological research renders
contraception more and more abortifacient. This does not seem to concern
public opinion so much, ever since it was decreed that the early embryo
was not an embryo. What would have been a major obstacle to
contraception at the time of the encyclical Humanae Vitae is now accepted
without resistance. This is either through ignorance or voluntary, selfinflicted blindness coming from the contraceptive mentality. Finally, the
distinction between contraception and abortion becomes more blurred
every day. It even disappears with the "menstrual regulation method"So,
using mijepris/one , the famous abortive pill RU_486 s1 , promoted by Pro
Etienne-Emile Baulieu. s2 The same drug, RU-486, can be used either as a
"contraceptive" or "contragestative" to induce an early abortion.
2) Oral contraception, far from being, as its promoters claimed, "the most
effective remedy against abortion" (Evangelium Vitae 13) finds today
abortion as its ultimate development. This, after contraception has failed.
It is misleading to promote contraception as an antidote to abortion; it is
slanderous to accuse those who oppose contraception as promoting
abortion. The fact is, contraception and abortion are interconnected, "fruits
of the same tree."
3) The root of the problem seems to lie in the contraceptive mentality,
which seeks to exclude the procreative aspect of sexual acts and to remove
all responsibility for the procreative consequences when they do occur.
This bears the hallmark of behavioral characteristics of modem liberal
society: a "self-centered concept of freedom " (EVI3) , a denial of truth.
4) The solution to the problem of responsible parenthood does not lie in the
spread of contraception. The Church asks parents to procreate in a
responsible, reasonable way for the sake of their children. Periodic
continence and other natural methods, seem to be the real answer. Using
periodic continence, parents do not deny the reality of sexual acts and do
not reject their procreative dimension . They simply abstain from carrying
out the acts which may lead to procreation. The embryo is still respected
for what it is - a human being - and parents assume their responsibility in
accepting the child when it comes. There is no room for abortion. We can
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add that these so-called "natural methods" have been used for years now,
and that their scientific efficacy is well recognized. 83
Thirty years after the publication of Humanae Vitae the prophetic
character of this document appears more and more obvious. At that time,
Pope Paul VI did not have the data which are now at our disposal. He
could not know for certain that the spread of the pill would not bring about
the expected decrease in abortions. He could not know for certain that this
would create havoc in new families , exaggerate the tendency of people
toward self-centered attitudes and self-blindness, and would bring the
disastrous consequences which we know today.
Despite this lack of certain knowledge, the Pope stood firm in his
condemnation of the pill. However, his attitude was not one of blind
intransigence. It is because Pope Paul VI fully understood the far-reaching
consequences of the voluntary dissociation of the union between
procreation and sexual acts that he could stand fast. The last thirty years of
unabated contraception have drained the resources of international
institutions, without bringing the peace, joy, and harmony predicted by
Margaret Sanger. The Pope was right when he considered "the pill" not as
a gift from science but as Pandora' s box.
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